Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

被引:66
|
作者
Mashiba, T
Burr, DB
Turner, CH
Sato, M
Cain, RL
Hock, JM
机构
[1] Indiana Univ, Sch Med, Res Ctr, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Res Ctr, Dept Orthoped Surg Biomech & Biomat, Indianapolis, IN 46202 USA
[3] Lilly Res Labs, Indianapolis, IN USA
关键词
parathyroid hormone (PTH); mechanical property; bone remodeling; cortical porosity; osteoporosis;
D O I
10.1016/S8756-3282(01)00433-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously shown that parathyroid hormone (PTH) increases cortical bone mass and mechanical strength of female rabbits after 140 days of treatment. However, cortical porosity was also shown to increase. If cortical porosity increases prior to the change in geometry, there may be a transient decrease in cortical bone strength that could make the bone more susceptible to fracture in the early phase of treatment. The purpose of this study is to examine the effects of PTH on the remodeling dynamics and mechanical properties of cortical bone in rabbits, which exhibit haversian remodeling, during the first remodeling cycle after the initiation of treatment. Fifty 9-month-old intact female New Zealand white rabbits were randomized into five groups. A baseline control group was killed at the start of the experiment. The two PTH-treated groups were given human PTH(1-34) at 10 mug/kg daily subcutaneously for 35 (P35) or 70 (P70) days. Two respective age-matched control groups (V35, V70) were injected with vehicle. Histomorphometry of the cortical bone in the tibial midshaft showed that, although intracortical activation frequency was significantly increased by PTH at 35 days, there was no significant increase of cortical porosity in the first remodeling cycle (70 days). Moreover, stimulation of cortical surface bone formation in the treated animals led to significantly greater cortical area and greater bone strength in both P35 and P70, We conclude that, although intracortical remodeling increases within the first remodeling period (70 days) in animals treated with 10 mug/kg PTH, the greater cortical area due to acceleration of bone formation on cortical surfaces increases cortical bone strength. There is no mechanical risk during the first remodeling cycle associated with intermittent PTH treatment in animals with normal bone mass. (C) 2001 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:538 / 547
页数:10
相关论文
共 50 条
  • [1] Early effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 804 - 804
  • [2] Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits
    Hirano, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (04) : 536 - 545
  • [3] Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.
    Hyldstrup, L
    Jorgensen, JT
    Gaich, G
    [J]. BONE, 2001, 28 (05) : S97 - S98
  • [4] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys
    Brommage, R
    Hotchkiss, CE
    Lees, CJ
    Stancill, MW
    Hock, JM
    Jerome, CP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3757 - 3763
  • [5] Effects of LY333334 [recombinant parathyroid hormone (1-34)] on cortical bone strength indices as assessed by peripheral quantitative computed tomography.
    Zanchetta, JR
    Bogado, C
    Ferretti, JL
    Wang, O
    Sato, M
    Gaich, GA
    [J]. BONE, 2001, 28 (05) : S86 - S86
  • [6] Effects of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium on markers of bone metabolism in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S530 - S530
  • [7] In vivo and in vitro comparison of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), with synthetic hPTH(1-34).
    Black, EC
    Frolik, CA
    Hock, JM
    Cain, RL
    Chandrasekhar, S
    Harvey, AK
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F370 - F370
  • [8] In primates, treatment with PTH (1-34), LY333334, increases bone strength at trabecular bone sites without compromising the strength of cortical bone.
    Turner, CH
    Wang, T
    Hirano, T
    Burr, DB
    Hock, JM
    Hotchkiss, CE
    Brommage, R
    Jerome, CP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S414 - S414
  • [9] In monkeys, treatment with PTH(1-34), LY333334, increases bone strength in lumbar vertebrae and the femoral neck without compromising cortical bone strength
    Turner, CH
    Wang, T
    Hirano, T
    Burr, DB
    Hock, JM
    Hotchkiss, CE
    Brommage, R
    Jerome, CP
    [J]. SIROT 99, 1999, : 107 - 110
  • [10] Regulation of caspase activity in trabecular bone of young rats treated once daily with human parathyroid hormone, rhPTH 1-34, (LY333334) for up to 6 days.
    Stanislaus, D
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S286 - S286